Gufic Biosciences Limited to Establish Philippines Subsidiary for Pharmaceutical Expansion
Gufic Biosciences Limited has approved the incorporation and investment in a subsidiary in the Philippines to facilitate its expansion into the Southeast Asian market. The initiative is set to strengthen the company’s presence and business operations within the Philippine pharmaceutical landscape.The proposed subsidiary, which may be named Gufic Philippines Inc., will focus on managing marketing, sales, distribution, and related activities for Gufic Biosciences Limited's pharmaceutical products in the country. A key function of the new entity will also be to hold and manage Intellectual Property Rights (IPR) within the Philippines.
Gufic Biosciences Limited intends to fund this venture through a cash subscription into the equity share capital of the proposed subsidiary. The investment amount is capped at USD 250,000 (United States Dollars Two Hundred Fifty Thousand only).
The company plans to hold significant control over the new entity. Gufic Biosciences Limited proposes to maintain an approximate 99.99% stake in the equity share capital of the proposed subsidiary. The balance equity shareholding will be managed by the directors of the proposed subsidiary, ensuring that Gufic maintains controlling interest.
Key details regarding the planned investment and the new entity are summarized below:
| Particulars | Details |
|---|---|
| Proposed Entity Name | Gufic Philippines Inc. or a name approved by regulatory authorities in the Philippines. |
| Country of Incorporation | Philippines |
| Industry Sector | Pharmaceuticals |
| Nature of Investment | Cash subscription to equity share capital |
| Investment Amount | Up to USD 250,000 (United States Dollars Two Hundred Fifty Thousand only) |
| Shareholding Control | Gufic Biosciences Limited proposes to hold approximately 99.99% of the equity share capital. |
GUFICBIO Stock Price Movement
Shares of Gufic Biosciences Limited slipped on Friday to settle at ₹422.20, shedding 2.27% from the previous day's close. The stock finished the session trading in a range and saw total activity reach 165,948 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.